MedTrace Logo

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

NCT04742816 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2022-03-03

No results posted yet for this study

Summary

Will use a subset of the main study cohort of transgender or non-binary individuals to evaluate the relationships between self-reported exogenous hormone use, endogenous hormone values, renal biomarkers, drug levels and directly measured renal function.

Conditions

  • Transgender
  • Renal Function
  • Hormone Replacement Therapy

Interventions

DIAGNOSTIC_TEST

IHX-CL measurements

The distribution of measured IHX-CL values and other continuous variables will be assessed to ensure a parametric distribution.

DRUG

Iohexol

Iohexol clearance measurement

Sponsors & Collaborators

Principal Investigators

  • Nimish Patel, PharmD · UC San Diego AntiViral Research Center (AVRC)

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-17
Primary Completion
2021-12-31
Completion
2021-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04742816 on ClinicalTrials.gov